Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDarktrace Regulatory News (DARK)

Share Price Information for Darktrace (DARK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 439.40
Bid: 439.10
Ask: 440.00
Change: 11.40 (2.66%)
Spread: 0.90 (0.205%)
Open: 425.30
High: 440.90
Low: 424.00
Prev. Close: 428.00
DARK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Open Trading Update

15 Jul 2021 07:00

RNS Number : 2880F
Darktrace PLC
15 July 2021
 

15th July 2021

Darktrace plc Pre-Open Trading Update

Strong FY 2021 performance and increased expectations for FY 2022

 

Darktrace plc (DARK.L) (together with its subsidiaries, "Darktrace" or "the Group") a global leader in cyber security AI, today provides a trading update for its financial year ended 30th June 2021.

Operating and Financial Performance

Darktrace demonstrated the resilience of its business model over the course of a universally challenging year. The Group ended FY 2021 with approximately 5,600 customers, having grown its customer base by 42% year-on-year.

The Group also delivered strong results in its constant currency Annualized Recurring Revenue (ARR). At its FY 2021 constant currency rates, Darktrace expects ARR at 30th June 2021 of at least $340 million, which represents year-over-year growth in constant currency ARR of at least 44%. Darktrace also reports that its one-year gross ARR churn and net ARR retention rate have remained in the range of recent reported periods.

Darktrace also expects revenue for FY 2021 of at least $278 million, reflecting year-over-year growth of at least 40%. It also expects that gross margin for FY 2021 has remained in the range of recent reported periods.

FY 2022 Outlook

To enable a consistent basis for evaluating its performance, Darktrace reports ARR in constant currency, at rates established at the start of each year(1). Applying FY 2022 rates to the Group's ARR balance for 30 June 2021, and all prior comparison periods, results in a rebased ARR balance of at least $354 million. This will become the new amount against which it will measure constant currency ARR growth for FY 2022.

 

Darktrace is increasing its expectations for FY 2022 from those presented at the time of IPO. The Group is balancing strong sales trends exiting the second half of FY 2021, including particularly strong June performance, with potential temporary sales productivity impacts that may occur as it evolves ways to expand and optimise its salesforce structure. These efforts will begin in the first half of FY 2022 and are intended to support anticipated growth and continued scaling of its business.

 

Darktrace now expects a year-over year increase in its constant currency ARR of between 32% and 34% (previously 26.5% to 29.5%). It also now expects year-over-year revenue growth of between 29% and 32% (previously 27% to 30%), considering normal quarterly seasonality patterns and particularly, typically soft first-quarter sales.

Darktrace reaffirms its prior commentary regarding its expected cost structure for FY 2022 and adds that it now expects an adjusted EBITDA margin for the year of between 1% and 4%.

(1) The Group's primary currency exposures are the British Pound and the Euro converting to its US Dollar reporting currency. For FY 2022, it is using constant currency rates of 1.3835 and 1.1878 for the Pound and the Euro, respectively. For FY 2021, constant currency rates were 1.2368 and 1.1235 for the Pound and the Euro, respectively.

 

Poppy Gustafsson, CEO of Darktrace said:

"We are pleased to report strong operating and financial performance for FY2021. Demand for our Self-Learning AI solutions is robust, as advanced cyber-attacks continue to outpace the human capability of security teams.

I would like to thank our shareholders for their interest and engagement: we have been delighted by the warm welcome we have received in the London market. I would also like to thank our customers and employees. We have executed well this past year, despite a challenging environment, and continue to invest in our business for the long-term success of all stakeholders."

Reporting Full Year Results

Darktrace intends to report its FY 2021 results the week of 13th September 2021. The reporting date, along with conference call details, will be made available in due course.

 

About Darktrace

Darktrace (DARK:L), a global leader in cyber security AI, delivers world-class technology that protects over 5,000 customers worldwide from advanced threats, including ransomware and cloud and SaaS attacks. The company's fundamentally different approach applies Self-Learning AI to enable machines to understand the business in order to autonomously defend it. Headquartered in Cambridge, UK, the company has 1,500 employees and over 30 offices worldwide. Darktrace was named one of TIME magazine's 'Most Influential Companies' for 2021.

 

Cautionary Statement

This announcement contains certain forward-looking statements, including with respect to the Company's current targets, expectations and projections about future performance, anticipated events or trends and other matters that are not historical facts. These forwardlooking statements, which sometimes use words such as "aim", "anticipate", "believe", "intend", "plan", "estimate", "expect" and words of similar meaning, include all matters that are not historical facts and reflect the directors' beliefs and expectations, made in good faith and based on the information available to them at the time of the announcement. Such statements involve a number of risks, uncertainties and assumptions that could cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forwardlooking statement and should be treated with caution. Any forward-looking statements made in this announcement by or on behalf of Darktrace speak only as of the date they are made. Except as required by applicable law or regulation, Darktrace expressly disclaims any obligation or undertaking to publish any updates or revisions to any forward-looking statements contained in this announcement to reflect any changes in its expectations with regard thereto or any changes in events, conditions or circumstances on which any such statement is based.

 

Enquiries:

Luk Janssens - Investor Relations Darktrace

Direct: +44 7811 027918

luk.janssens@darktrace.com

 

Powerscourt (Public Relations adviser to the Company)

Victoria Palmer-Moore/Elly Williamson

Direct: +44 20 7549 0745

 

darktrace@powerscourt-group.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBCGDRUUBDGBS
Date   Source Headline
26th Mar 20245:32 pmRNSHolding(s) in Company
25th Mar 202411:54 amRNSIssue & Allotment of Shares & Total Voting Rights
22nd Mar 20247:00 amRNSResult of Secondary Placing in Darktrace
21st Mar 20244:42 pmRNSProposed Secondary Placing in Darktrace
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20244:04 pmRNSDirector/PDMR Shareholding
13th Mar 202410:23 amRNSHolding(s) in Company
11th Mar 202410:42 amRNSHolding(s) in Company
7th Mar 20247:00 amRNSHalf-Year Results
5th Mar 20241:00 pmRNSDarktrace Federal: High "In Process" Designation
5th Mar 20247:00 amRNSDarktrace Appoints Chief People Officer
29th Feb 20244:53 pmRNSTotal Voting Rights
26th Feb 20243:31 pmRNSHolding(s) in Company
31st Jan 20244:45 pmRNSTotal Voting Rights
23rd Jan 20243:04 pmRNSHolding(s) in Company
15th Jan 20241:58 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNS1H FY 2024 Trading Update
3rd Jan 202411:39 amRNSIssue & Allotment of Shares & Total Voting Rights
2nd Jan 20247:00 amRNSTotal Voting Rights
27th Dec 20234:06 pmRNSHolding(s) in Company
27th Dec 20237:00 amRNSHolding(s) in Company
19th Dec 20235:18 pmRNSDirector/PDMR Shareholding
7th Dec 20232:09 pmRNSResult of AGM
30th Nov 20234:41 pmRNSTotal Voting Rights
29th Nov 20234:18 pmRNSDirector/PDMR Shareholding
22nd Nov 20239:13 amRNSAppointment of Independent Non-Executive Directors
20th Nov 20232:53 pmRNSHolding(s) in Company
7th Nov 20235:57 pmRNSNotice of AGM
7th Nov 20237:00 amRNSDarktrace Hosts Inaugural Technology Day
1st Nov 20237:00 amRNSEBT Market Purchase Programme
1st Nov 20237:00 amRNSTransaction in Own Shares
31st Oct 20235:08 pmRNSTotal Voting Rights
31st Oct 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20237:00 amRNSDarktrace Unveils New Cloud Security Solution
26th Oct 20237:00 amRNSTransaction in Own Shares
24th Oct 20237:00 amRNSTransaction in Own Shares
23rd Oct 20237:00 amRNSTransaction in Own Shares
20th Oct 20237:00 amRNSTransaction in Own Shares
19th Oct 20231:45 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSTransaction in Own Shares
18th Oct 20237:00 amRNSTransaction in Own Shares
17th Oct 202310:01 amRNSTransaction in Own Shares
16th Oct 20231:02 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSQ1 FY 2024 Trading Update
22nd Sep 202310:57 amRNSHolding(s) in Company
18th Sep 20231:55 pmRNSHolding(s) in Company
15th Sep 20234:33 pmRNSHolding(s) in Company - Replacement
15th Sep 20231:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.